ARCHIVES

Amgen’s Aranesp Sales Dropped By Half, Continue To Fall.

This article is from The Cancer Letter archive.

Vol. 34 No. 42 | November 14, 2008

Download PDF Visit The Full Archive

Related Articles

In Brief: AMOS Says Cancer Program Should Not Have Ceiling Of $1 Billion; OSHA Drops Effort To Fire Infants

August 14, 1981

NCI Committee Attempts To Redesign Cooperative Groups Without Doing Harm

June 12, 1998

Bevacizumab And Irinotecan May Increase Survival Of GBM

October 26, 2007

NY Attorney General Sues Drug Companies Over Cancer Drug Pricing Deals

February 14, 2003

New Biomedical Research Panel Accepts Broad Mandate. May Suggest Separate Health Dept.

February 28, 1975

In Brief: Less Hazardous Cigarette Only Hope To Reduce Smoking Health Problems, Carter Advisor Says

November 25, 1977